Form 4 for ELVN Enliven Therapeutics, Inc.
Accepted 2025-09-25 00:00:00 ET · period of report 2025-09-23 · accession 0001967150-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-09-25 | 2025-09-23 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $20.03 | -1,500 | 931.7K | -0.2% | -$30.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-23 | S | D | 1,500 | $20.03 | 931,688 | I See footnote | — | — | (F2) The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee. |